Company profile: myTomorrows
1.1 - Company Overview
Company description
- Provider of a global platform connecting patients with unmet medical needs and their doctors to information and access to clinical trials and expanded access programs, offering patient navigation, healthcare professional support, patient pre-screening and referral, expanded access program management (regulatory support, logistics), and BioPharma services including recruitment and real-world data collection.
Products and services
- BioPharma Services: Architects a global-scale platform for patient recruitment to clinical trials, managing expanded access programs end-to-end, and capturing real-world data for BioPharma companies
- Expanded Access Program Management: Produces regulatory-grade management of expanded access programs, handling regulatory support, logistics coordination, and real-world data collection to facilitate access to medicines in development
- Patient Navigation Services: Delivers custom-tailored guidance for patients and families to locate clinical trials and expanded access programs worldwide, offering personalized support throughout information discovery and access facilitation
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to myTomorrows
Eclipse Solutions
HQ: United States
Website
- Description: Provider of clinical technology with data management, biostatistics, consulting, and certified medical and drug coding solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eclipse Solutions company profile →
BioPharmics
HQ: United States
Website
- Description: Provider of AI-based drug design and modeling tools for researchers and scientists, offering algorithms and software for computational drug design, including 2D-to-3D ligand conversion, conformer generation, molecular docking, molecular similarity, binding affinity prediction, and real-space modeling of ligand ensembles in X-ray density maps.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioPharmics company profile →
Chemical Computing Group
HQ: Canada
Website
- Description: Provider of research software for computational chemistry, including Molecular Operating Environment (MOE) for molecular modeling and simulations across small molecules, peptides, and biologics; MOEsaic for real-time docking visualization, SAR analysis, and property modeling; PSILO, a protein structure database integrating public, private, and AlphaFold data with cryo-EM support and deposit validation; and a Discovery Platform for chemists, biologists, and crystallographers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Chemical Computing Group company profile →
Presa Solutions
HQ: United States
Website
- Description: Provider of design, implementation, and management of supply chain solutions for pharmaceutical manufacturers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Presa Solutions company profile →
eClinical Solutions
HQ: United States
Website
- Description: Provider of a data intelligence hub that transforms clinical data integration, aggregation, and analytics, leveraging clinical trial expertise and platforms including Rave Clinical Cloud and the elluminate Clinical Data Cloud; offerings include Mapper, Data Central, Clinical Analytics, Risk-Based Quality Management, and eIQ Review to accelerate clinical development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full eClinical Solutions company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for myTomorrows
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to myTomorrows
2.2 - Growth funds investing in similar companies to myTomorrows
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for myTomorrows
4.2 - Public trading comparable groups for myTomorrows
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →